Literature DB >> 17385019

Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures.

Grace C Chu1, Dirk Chelius, Gang Xiao, Hui K Khor, Sururat Coulibaly, Pavel V Bondarenko.   

Abstract

PURPOSE: The purpose of this paper was to identify the location of a succinimide and determine the rate of its formation and hydrolysis in a recombinant human monoclonal IgG2 antibody aged in mildly acidic buffers at elevated temperatures.
MATERIALS AND METHODS: Cation exchange (CEX) HPLC separated multiple Main Peaks and high levels (up to 50%) of basic variants, the identification of which was an analytical challenge and required several complementary techniques. The relative abundance of the CEX basic variants was used to quantify the percentage of succinimide and to study the rates of its formation and hydrolysis.
RESULTS: Mass decrease by approximately 18 Da for intact antibodies from the CEX basic fractions suggested succinimide formation from aspartic acid as the major modification. Reversed-phase HPLC/MS of the reduced and trypsin-digested samples detected an isoaspartate 30 (isoD30) in the light chain peptide A25-R37. Direct evidence that isoD30 was from succinimide was obtained by performing succinimide hydrolysis in H2(18)O followed by tryptic digestion in H2(16)O.
CONCLUSIONS: Succinimide formation increased as pH became more acidic, whereas its hydrolysis was faster as pH became neutral and alkaline. Succinimide hydrolysis in a denatured sample was estimated to have completed in less than 2 h, but approximately three days for a similar pH but without denaturant. These observations suggest that protein conformation affects succinimide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17385019     DOI: 10.1007/s11095-007-9241-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  29 in total

1.  Prediction of low-energy collision-induced dissociation spectra of peptides.

Authors:  Zhongqi Zhang
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

2.  Quantification of the isomerization of Asp residue in recombinant human alpha A-crystallin by reversed-phase HPLC.

Authors:  Yutaka Sadakane; Toshiaki Yamazaki; Kazuya Nakagomi; Toshifumi Akizawa; Noriko Fujii; Takenori Tanimura; Masaki Kaneda; Yasumaru Hatanaka
Journal:  J Pharm Biomed Anal       Date:  2003-01-15       Impact factor: 3.935

3.  Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2.

Authors:  X M Lam; J Y Yang; J L Cleland
Journal:  J Pharm Sci       Date:  1997-11       Impact factor: 3.534

4.  Intracellular protein modification associated with altered T cell functions in autoimmunity.

Authors:  Mei-Ling Yang; Hester A Doyle; Renelle J Gee; Jonathan D Lowenson; Steven Clarke; Brian R Lawson; Dana W Aswad; Mark J Mamula
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Optimization of a reversed-phase high-performance liquid chromatography/mass spectrometry method for characterizing recombinant antibody heterogeneity and stability.

Authors:  Thomas M Dillon; Pavel V Bondarenko; Douglas S Rehder; Gary D Pipes; Gerd R Kleemann; Margaret Speed Ricci
Journal:  J Chromatogr A       Date:  2006-01-30       Impact factor: 4.759

6.  Chemical pathways of peptide degradation. IV. Pathways, kinetics, and mechanism of degradation of an aspartyl residue in a model hexapeptide.

Authors:  C Oliyai; R T Borchardt
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

7.  Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.

Authors:  T Geiger; S Clarke
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

8.  Incorporation of two 18O atoms into a peptide during isoaspartyl repair reveals repeated passage through a succinimide intermediate.

Authors:  J A Lindquist; P N McFadden
Journal:  J Protein Chem       Date:  1994-08

9.  Sequence-specific deamidation: isolation and biochemical characterization of succinimide intermediates of recombinant hirudin.

Authors:  R Bischoff; P Lepage; M Jaquinod; G Cauet; M Acker-Klein; D Clesse; M Laporte; A Bayol; A Van Dorsselaer; C Roitsch
Journal:  Biochemistry       Date:  1993-01-19       Impact factor: 3.162

10.  Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.

Authors:  J Cacia; R Keck; L G Presta; J Frenz
Journal:  Biochemistry       Date:  1996-02-13       Impact factor: 3.162

View more
  25 in total

1.  Understanding the pathway and kinetics of aspartic acid isomerization in peptide mapping methods for monoclonal antibodies.

Authors:  June Kuang; Yuanqi Tao; Yuanli Song; Letha Chemmalil; Nesredin Mussa; Julia Ding; Zheng Jian Li
Journal:  Anal Bioanal Chem       Date:  2021-02-05       Impact factor: 4.142

2.  Molecular mass analysis of antibodies by on-line SEC-MS.

Authors:  Lowell J Brady; John Valliere-Douglass; Theresa Martinez; Alain Balland
Journal:  J Am Soc Mass Spectrom       Date:  2008-01-04       Impact factor: 3.109

3.  Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap-Orbitrap mass spectrometer.

Authors:  Pavel V Bondarenko; Tonya P Second; Vlad Zabrouskov; Alexander A Makarov; Zhongqi Zhang
Journal:  J Am Soc Mass Spectrom       Date:  2009-03-28       Impact factor: 3.109

Review 4.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

Review 5.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

6.  Mass spectrometric distinction of in-source and in-solution pyroglutamate and succinimide in proteins: a case study on rhG-CSF.

Authors:  Mukesh Kumar; Amarnath Chatterjee; Anand P Khedkar; Mutyalasetty Kusumanchi; Laxmi Adhikary
Journal:  J Am Soc Mass Spectrom       Date:  2013-01-03       Impact factor: 3.109

Review 7.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Authors:  Yi Du; Alison Walsh; Robin Ehrick; Wei Xu; Kimberly May; Hongcheng Liu
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

8.  Comparison of the in vitro and in vivo stability of a succinimide intermediate observed on a therapeutic IgG1 molecule.

Authors:  David Ouellette; Chris Chumsae; Anca Clabbers; Czeslaw Radziejewski; Ivan Correia
Journal:  MAbs       Date:  2013-04-22       Impact factor: 5.857

9.  Mass Spectrometry Based Mechanistic Insights into Formation of Tris Conjugates: Implications on Protein Biopharmaceutics.

Authors:  Pradeep G Kabadi; Praveen Kallamvalliillam Sankaran; Dinesh V Palanivelu; Laxmi Adhikary; Anand Khedkar; Amarnath Chatterjee
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-03       Impact factor: 3.109

Review 10.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.